Home › Funds › D. E. Shaw & Co › ESPR
D. E. Shaw & Co position in ESPR
ESPERION THERAPEUTICS INC NE
Latest position (Q1 2026)6.54M sh
Reported value held$17.92M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 35.58K | $429.00K | New |
| Q4 2021 | 896.97K | $4.49M | Add |
| Q1 2022 | 637.44K | $2.96M | Reduce |
| Q2 2022 | 703.48K | $4.47M | Add |
| Q3 2022 | 351.04K | $2.35M | Reduce |
| Q4 2023 | 1.21M | $3.63M | New |
| Q1 2024 | 5.14M | $13.78M | Add |
| Q2 2024 | 382.49K | $849.12K | Reduce |
| Q3 2024 | 99.57K | $164.30K | Reduce |
| Q4 2024 | 251.59K | $553.50K | Add |
| Q1 2025 | 275.71K | $397.02K | Add |
| Q3 2025 | 208.63K | $552.88K | New |
| Q4 2025 | 6.90M | $25.54M | Add |
| Q1 2026 | 6.54M | $17.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ESPR
- BlackRock Inc 22.13M sh · $69.92M · Q2 2026
- Vanguard Group 14.95M sh · $55.30M · Q4 2025
- Goldman Sachs Group 10.38M sh · $32.80M · Q2 2026
- Two Sigma Investments 7.13M sh · $22.52M · Q2 2026
- Geode Capital Management 6.63M sh · $20.96M · Q2 2026
- Balyasny Asset Management 4.65M sh · $14.71M · Q2 2026
- Fidelity Management & Research (FMR) 4.61M sh · $14.58M · Q2 2026
- UBS Group AG 3.84M sh · $12.12M · Q2 2026
- Northern Trust Corp 2.32M sh · $7.34M · Q2 2026
- Millennium Management 2.23M sh · $7.03M · Q2 2026
- Fidelity International (FIL) 2.11M sh · $6.66M · Q2 2026
- JPMorgan Chase & Co 1.40M sh · $4.40M · Q2 2026